ConductScience.org, home

Paper24319166

Current concepts in the pathophysiology and treatment of aplastic anemia.

Young NS. Hematology Am Soc Hematol Educ Program, 2013. Cited by 161 papers, by iCite.

Cite this record

ConductScience Library. Current concepts in the pathophysiology and treatment of aplastic anemia. Papers, record 24319166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24319166

Download JSON
Disease
aplastic anemia62 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Current concepts in the pathophysiology and treatment of aplastic anemia.
PubMed
Journal
Hematology Am Soc Hematol Educ Program
PubMed
Year
2013
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
161
iCite
Relative citation ratio, by iCite
5.01
iCite
Revised in PubMed
2022-04-08
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Young NSNeal S

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anemia, AplasticMajor topic
Hematopoietic Stem CellsMajor topic
Immunosuppression TherapyMajor topic
Stem Cell TransplantationMajor topic
Disease-Free Survival
Female
Humans
Male

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
ZIAHL002315NIH

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02828592Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic AnemiaResults

Source ClinicalTrials.gov

Download CSV of trials

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122005790Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia.Leukemia2012https://conductscience.org/library/papers/22005790PubMed
222859607STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.Blood2012https://conductscience.org/library/papers/22859607PubMed
322517900How I treat acquired aplastic anemia.Blood2012https://conductscience.org/library/papers/22517900PubMed
421367725Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades.Clin Infect Dis2011https://conductscience.org/library/papers/21367725PubMed
522476886Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation.Ann Hematol2012https://conductscience.org/library/papers/22476886PubMed
68639762Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction.Blood1996https://conductscience.org/library/papers/8639762PubMed
723554855Outcomes of optimized over standard protocol of rabbit antithymocyte globulin for severe aplastic anemia: a single-center experience.PLoS One2013https://conductscience.org/library/papers/23554855PubMed
824319167Allogeneic BM transplantation for the treatment of aplastic anemia: current results and expanding donor possibilities.Hematology Am Soc Hematol Educ Program2013https://conductscience.org/library/papers/24319167PubMed
923487025Interferon-γ impairs proliferation of hematopoietic stem cells in mice.Blood2013https://conductscience.org/library/papers/23487025PubMed
1023116478Improved outcome of adults with aplastic anaemia treated with arsenic trioxide plus ciclosporin.Br J Haematol2013https://conductscience.org/library/papers/23116478PubMed
1119036108Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia.Br J Haematol2009https://conductscience.org/library/papers/19036108PubMed
1217463169Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia.Blood2007https://conductscience.org/library/papers/17463169PubMed
1322348483How I manage aplastic anaemia in children.Br J Haematol2012https://conductscience.org/library/papers/22348483PubMed
1424216168Mouse medicine and human biology.Semin Hematol2013https://conductscience.org/library/papers/24216168PubMed
1510583220
Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
Br J Haematol1999https://conductscience.org/library/papers/10583220PubMed
1623370706Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia.Leukemia2013https://conductscience.org/library/papers/23370706PubMed
1722965356The telomere syndromes.Nat Rev Genet2012https://conductscience.org/library/papers/22965356PubMed
1824216172Aplastic anemia: what have we learned from animal models and from the clinic.Semin Hematol2013https://conductscience.org/library/papers/24216172PubMed
1919415736Dyskeratosis congenita: the first NIH clinical research workshop.Pediatr Blood Cancer2009https://conductscience.org/library/papers/19415736PubMed
2019561322Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells.Blood2009https://conductscience.org/library/papers/19561322PubMed

See all 34 referencesDownload CSV of references

Cited by101

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 161 citations.

PMIDTitleJournalYearIn PapersSource
42774213Linking HLA class II susceptibility to HSPC transcriptomics and antigen presentation in aplastic anemia.Front Immunol2026https://conductscience.org/library/papers/42774213PubMed
42661903Real-world retrospective analysis of clinical outcomes in pediatric acquired aplastic anemia: a single-center 10-year cohort study.Front Pediatr2026https://conductscience.org/library/papers/42661903PubMed
42558397Initiation timing and treatment duration of eltrombopag added to immunosuppressive therapy in aplastic anemia: a systematic review and meta-analysis.Front Oncol2026https://conductscience.org/library/papers/42558397PubMed
42269078PTCy-based allo-BMT platform as a curative, accessible alternative for pediatric and young adult severe aplastic anemia.Blood Adv2026https://conductscience.org/library/papers/42269078PubMed
41821147Plasma Elastase Screening in Hematological Disease Reveals Its Potential as a Diagnostic and Prognostic Biomarker in Hematological Malignancies.Int J Lab Hematol2026https://conductscience.org/library/papers/41821147PubMed
41296017Clonal hematopoiesis may precede the diagnosis of aplastic anemia by several years.Blood Adv2026https://conductscience.org/library/papers/41296017PubMed
40830475Lactic acidosis in hemophagocytic syndrome: diagnostic and therapeutic challenges in the intensive care unit-a case series.J Med Case Rep2025https://conductscience.org/library/papers/40830475PubMed
40515826Good response to oxymetholone in adult aplastic anemia.Ann Hematol2025https://conductscience.org/library/papers/40515826PubMed
39619872Potential of ginsenoside Rg1 to treat aplastic anemia via mitogen activated protein kinase pathway in cyclophosphamide-induced myelosuppression mouse model.World J Stem Cells2024https://conductscience.org/library/papers/39619872PubMed
38527010Establishment of reference interval for hemoglobin A1C and other hemoglobin subfractions for healthy Saudi adults.PLoS One2024https://conductscience.org/library/papers/38527010PubMed
38525441The role of TIM3+ NK and TIM3- NK cells in the immune pathogenesis of severe aplastic anemia.J Transl Int Med2024https://conductscience.org/library/papers/38525441PubMed
38314248Predictive value of thyroid function in severe aplastic anemia patients treated with immunosuppressive therapy.Blood Sci2024https://conductscience.org/library/papers/38314248PubMed
38302378Indigenous antithymocyte globulin-equine to treat aplastic anaemia in adults: a case series from two centres in northeast India.Hematol Transfus Cell Ther2024https://conductscience.org/library/papers/38302378PubMed
38238183
Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trials.
BMJ Open2024https://conductscience.org/library/papers/38238183PubMed
38138273All Roads Lead to Interferon-γ: From Known to Untraveled Pathways in Acquired Aplastic Anemia.Medicina (Kaunas)2023https://conductscience.org/library/papers/38138273PubMed
38074827Effect of Stanozolol combined with Cyclosporine A on aplastic anemia.Am J Transl Res2023https://conductscience.org/library/papers/38074827PubMed
37289327Repair of dysfunctional bone marrow endothelial cells alleviates aplastic anemia.Sci China Life Sci2023https://conductscience.org/library/papers/37289327PubMed
37062051Epigenetic regulation by ASXL1 in myeloid malignancies.Int J Hematol2023https://conductscience.org/library/papers/37062051PubMed
37021397Alemtuzumab in relapsed immune severe aplastic anemia: Long-term results of a phase II study.Am J Hematol2023https://conductscience.org/library/papers/37021397PubMed
36405262What is responsible for acute myocardial infarction in combination with aplastic anemia? A case report and literature review.World J Clin Cases2022https://conductscience.org/library/papers/36405262PubMed

See all 101 cited byDownload CSV of cited by

Drugs2

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
CYCLOPHOSPHAMIDECHEMBL1200796Results1https://conductscience.org/library/drugs/CHEMBL1200796ChEMBL
FLUDARABINECHEMBL1568Results1https://conductscience.org/library/drugs/CHEMBL1568ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24319166

GET https://conductscience.org/api/papers/v1/24319166/references?page=2